These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16836293)

  • 1. Process chemistry: The science, business, logic, and logistics.
    Zhang TY
    Chem Rev; 2006 Jul; 106(7):2583-95. PubMed ID: 16836293
    [No Abstract]   [Full Text] [Related]  

  • 2. Advantages of neurofuzzy logic against conventional experimental design and statistical analysis in studying and developing direct compression formulations.
    Landín M; Rowe RC; York P
    Eur J Pharm Sci; 2009 Nov; 38(4):325-31. PubMed ID: 19716414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the scope of crystal form evaluation in pharmaceutical science.
    Peterson ML; Hickey MB; Zaworotko MJ; Almarsson O
    J Pharm Pharm Sci; 2006; 9(3):317-26. PubMed ID: 17207415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mark Fishman on changing the grammar of drug discovery. Interviewed by Christopher Watson.
    Fishman M
    Drug Discov Today; 2005 May; 10(9):609-11. PubMed ID: 15894223
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of microwave synthesis on drug discovery.
    Kappe CO; Dallinger D
    Nat Rev Drug Discov; 2006 Jan; 5(1):51-63. PubMed ID: 16374514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. March of the synthesis machines.
    Sanderson K
    Nat Rev Drug Discov; 2015 May; 14(5):299-300. PubMed ID: 25924572
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of the reactions used for the preparation of drug candidate molecules.
    Carey JS; Laffan D; Thomson C; Williams MT
    Org Biomol Chem; 2006 Jun; 4(12):2337-47. PubMed ID: 16763676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocatalysis for pharmaceutical intermediates: the future is now.
    Pollard DJ; Woodley JM
    Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the cellular targets of bioactive small organic molecules using affinity reagents.
    Leslie BJ; Hergenrother PJ
    Chem Soc Rev; 2008 Jul; 37(7):1347-60. PubMed ID: 18568161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boron reagents in process chemistry: Excellent tools for selective reductions.
    Burkhardt ER; Matos K
    Chem Rev; 2006 Jul; 106(7):2617-50. PubMed ID: 16836295
    [No Abstract]   [Full Text] [Related]  

  • 11. Enabling continuous-flow chemistry in microstructured devices for pharmaceutical and fine-chemical production.
    Kockmann N; Gottsponer M; Zimmermann B; Roberge DM
    Chemistry; 2008; 14(25):7470-7. PubMed ID: 18613163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery for optimised products: from product life-cycle management to first-generation product concepts.
    Bhatt PP
    Expert Opin Drug Deliv; 2005 Jan; 2(1):1-2. PubMed ID: 16296731
    [No Abstract]   [Full Text] [Related]  

  • 13. Enterprising drug company offers cash for chemicals.
    Adam D
    Nature; 2001 Aug; 412(6847):575. PubMed ID: 11493887
    [No Abstract]   [Full Text] [Related]  

  • 14. Ozonolysis applications in drug synthesis.
    Van Ornum SG; Champeau RM; Pariza R
    Chem Rev; 2006 Jul; 106(7):2990-3001. PubMed ID: 16836306
    [No Abstract]   [Full Text] [Related]  

  • 15. Asymmetric synthesis of active pharmaceutical ingredients.
    Farina V; Reeves JT; Senanayake CH; Song JJ
    Chem Rev; 2006 Jul; 106(7):2734-93. PubMed ID: 16836298
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in the generation of small-molecule combinatorial libraries: encoded split synthesis and solid-phase synthetic methodology.
    Baldwin JJ; Henderson I
    Med Res Rev; 1996 Sep; 16(5):391-405. PubMed ID: 8865148
    [No Abstract]   [Full Text] [Related]  

  • 17. How well do medicinal chemists learn from experience?
    Cheshire DR
    Drug Discov Today; 2011 Sep; 16(17-18):817-21. PubMed ID: 21704183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical assessment of pharmaceutical processes--A rationale for changing the synthetic route.
    Butters M; Catterick D; Craig A; Curzons A; Dale D; Gillmore A; Green SP; Marziano I; Sherlock JP; White W
    Chem Rev; 2006 Jul; 106(7):3002-27. PubMed ID: 16836307
    [No Abstract]   [Full Text] [Related]  

  • 19. Organolithium reagents in pharmaceutical asymmetric processes.
    Wu G; Huang M
    Chem Rev; 2006 Jul; 106(7):2596-616. PubMed ID: 16836294
    [No Abstract]   [Full Text] [Related]  

  • 20. Highlighting the new advances in drug discovery and development.
    Taliani S; Da Settimo F
    ChemMedChem; 2008 Jan; 3(1):181-4. PubMed ID: 18022978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.